...
首页> 外文期刊>Journal of Clinical Microbiology >Accuracy of Results Obtained by Performing a Second Ligase Chain Reaction Assay and PCR Analysis on Urine Samples with Positive or Near-Cutoff Results in the LCx Test for Chlamydia trachomatis
【24h】

Accuracy of Results Obtained by Performing a Second Ligase Chain Reaction Assay and PCR Analysis on Urine Samples with Positive or Near-Cutoff Results in the LCx Test for Chlamydia trachomatis

机译:在沙眼衣原体LCx试验中对阳性或接近截止结果的尿液样品进行第二次连接酶链反应测定和PCR分析获得的结果的准确性

获取原文
           

摘要

Nucleic acid amplification assays such as the ligase chain reaction and PCR have encountered reproducibility problems. The initial extract and a newly extracted aliquot of urine specimens (n = 120) which had signal-to-cutoff (S/CO) ratios above 0.80 by the LCx Chlamydia assay were retested. Nucleic acid was extracted from an additional urine sample for testing by the AMPLICOR PCR Chlamydia assay. Fifteen percent (18 of 120) of the urine specimens were negative by all repeat tests (initial mean S/CO ratio by the LCx Chlamydia assay, 0.93; S/CO ratio range, 0.80 to 3.30). Repeat testing of the 102 specimens with possible positive results by the LCx Chlamydia assay by use of the initially extracted aliquot confirmed the results for 95 (93.1%) of the specimens; repeat testing of a newly extracted aliquot confirmed the results for 87 (85.3%) of the specimens. Twenty specimens had discordant results by the two repeat LCx Chlamydia assays. A total of 78 of 102 (76.5%) of the specimens were positive by the AMPLICOR PCR, and the AMPLICOR PCR confirmed the results for 82.1% (78 of 95) and 89.6% (78 of 87) of the specimens positive by the two repeat LCx Chlamydia assays, respectively. Some of the discrepancies observed by multiple repeat tests may have been due to specimen mislabeling or contamination during performance of the procedure rather than to the LCx Chlamydia assay. Both assays suffered from a lack of reproducibility on repeat testing with a small proportion of specimens, probably due to the presence of low levels of DNA, the presence of variable amounts of amplification inhibitors, and the loss of DNA during extraction.
机译:诸如连接酶链反应和PCR之类的核酸扩增测定法遇到了再现性问题。通过LCx衣原体分析重新测试了尿液样本的初始提取物和新提取的等分试样( n = 120),这些样本的信噪比(S / CO)大于0.80。从另外的尿液样本中提取核酸,以进行AMPLICOR PCR衣原体检测。在所有重复测试中,百分之十五(120个中的18个)尿液样本均为阴性(LCx衣原体测定的初始平均S / CO比为0.93; S / CO比范围为0.80至3.30)。使用最初提取的等分试样,通过LCx衣原体测定法对102个标本进行重复测试,可能得到阳性结果,从而确认了95个标本的结果(93.1%);对新提取的等分试样进行重复测试,确认了87个样本(85.3%)的结果。通过两次重复LCx衣原体分析,有20个样品的结果不一致。通过AMPLICOR PCR,总共有102个样本中有78个(76.5%)呈阳性,而AMPLICOR PCR证实了两个样本分别为82.1%(95个中的78个)和89.6%(87个中的78个)的结果分别重复LCx衣原体检测。通过多次重复测试观察到的某些差异可能是由于在执行此过程中样品被错误标记或污染,而不是由于LCx衣原体检测所致。两种测定法在重复检测小比例样品时均缺乏可重复性,这可能是由于存在低水平的DNA,存在数量可变的扩增抑制剂以及提取过程中DNA的损失。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号